Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA for Inflammation-Related Anhedonia in Depression
NCT06075771Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Nov 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and anhedonia ((none)) comparing Carbidopa Levodopa Group with Placebo Group (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Started Nov 2023; status: recruiting.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)anhedonia ((none))
Beyond the preview
Go deeper on NCT06075771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06075771.